Your browser doesn't support javascript.
loading
Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase.
Anantharajan, Jothi; Baburajendran, Nithya; Lin, Grace; Loh, Yong Yao; Xu, Weijun; Ahmad, Nur Huda Binte; Liu, Shuang; Jansson, Anna E; Kuan, John Wee Liang; Ng, Elizabeth Yihui; Yeo, Yee Khoon; Hung, Alvin W; Joy, Joma; Hill, Jeffrey; Ford, Heide L; Zhao, Rui; Keller, Thomas H; Kang, CongBao.
Afiliación
  • Anantharajan J; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Baburajendran N; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Lin G; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Loh YY; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Xu W; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Ahmad NHB; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Liu S; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Jansson AE; Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Kuan JWL; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Ng EY; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Yeo YK; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Hung AW; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Joy J; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Hill J; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Ford HL; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Zhao R; Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Keller TH; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Kang C; Experimental Drug Development Centre, Agency for Science, Technology and Research (A*STAR), Singapore.
Protein Sci ; 31(2): 422-431, 2022 02.
Article en En | MEDLINE | ID: mdl-34761455
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteínas Tirosina Fosfatasas / Péptidos y Proteínas de Señalización Intracelular Límite: Humans Idioma: En Revista: Protein Sci Asunto de la revista: BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteínas Tirosina Fosfatasas / Péptidos y Proteínas de Señalización Intracelular Límite: Humans Idioma: En Revista: Protein Sci Asunto de la revista: BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos